395 filings
Page 3 of 20
8-K
8sv hux47ir6pt5
7 Mar 23
Termination of a Material Definitive Agreement
8:55am
8-K
5xrw3
17 Jan 23
Ampio Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
qtxej7kn
27 Dec 22
Regulation FD Disclosure
5:18pm
8-K
d7oylfuzp4aeehey6rgk
18 Nov 22
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension
4:26pm
8-K
h57m58tjk d0
9 Nov 22
Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split
4:22pm
8-K
av4rq12h867 x981
14 Oct 22
Ampio Pharmaceuticals Issues Letter to Stockholders
4:15pm
DEFA14A
d3d9iy5v
4 Oct 22
Additional proxy soliciting materials
9:07am
DEFA14A
vkde8p7f3nc213bo3vx
4 Oct 22
Additional proxy soliciting materials
8:59am
8-K
pwtkyufj 0n2
4 Oct 22
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
8:51am
8-K
53cg3za9q9ue
1 Sep 22
Departure of Directors or Certain Officers
4:52pm
8-K
9fcyh6aezlesomdzo9w
12 Aug 22
Submission of Matters to a Vote of Security Holders
7:01am
DEFA14A
8f2bnjdvfxnwjbrf0ev
4 Aug 22
Additional proxy soliciting materials
8:52am
DEFA14A
50xto7g5b oq
3 Aug 22
Additional proxy soliciting materials
8:39am
8-K
fe3n8s3k
3 Aug 22
Ampio Pharmaceuticals’ Chairman of the Board Kevin Buchi and CEO Mike Martino Issues Letter to Stockholders
8:36am
DEFA14A
g85wir9d
5 Jul 22
Additional proxy soliciting materials
8:56am